Ruggaard & Associates’s Eli Lilly LLY Stock Holding History

Ruggaard & Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$402K	Hold	437	–	–	0.16%	80
2025 Q4	$470K	Sell	437 -9	-2%	-$8.61K	0.18%	71
2025 Q3	$340K	Hold	446	–	–	0.13%	87
2025 Q2	$348K	Hold	446	–	–	0.14%	85
2025 Q1	$368K	Buy	446 +3	+0.7%	+$2.5K	0.16%	81
2024 Q4	$342K	Sell	443 -133	-23%	-$110K	0.15%	82
2024 Q3	$510K	Hold	576	–	–	0.22%	64
2024 Q2	$521K	Buy	576 +9	+2%	+$7.2K	0.24%	62
2024 Q1	$441K	Buy	567 +12	+2%	+$8.54K	0.21%	67
2023 Q4	$324K	Sell	555 -15	-3%	-$8.76K	0.17%	83
2023 Q3	$306K	Sell	570 -14	-2%	-$7.21K	0.18%	78
2023 Q2	$274K	Sell	584 -39	-6%	-$16.4K	0.16%	89
2023 Q1	$214K	Buy	+623	New	+$210K	0.13%	97

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ruggaard & Associates's LLY Position: Q1 2026 in Review

Ruggaard & Associates held its Eli Lilly (LLY) position steady in Q1 2026 at 437 shares worth $402K. The position accounts for 0.16% of the portfolio, ranked #80.

Ruggaard & Associates first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $521K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Ruggaard & Associates held 437 shares of Eli Lilly worth $402K as of Q1 2026.
Ruggaard & Associates left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.16% of Ruggaard & Associates's portfolio in Q1 2026, its #80 holding.
Ruggaard & Associates first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
Ruggaard & Associates's Eli Lilly position peaked at $521K in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ruggaard & Associates's 13F filing for Q1 2026, filed 26 May 2026.